1 venture capitalists actively investing in Biotechnology.
Partner, Capital Formation
Lux Capital
Kalish’s role at Lux is centered on capital formation rather than direct investing. Lux says he focuses on building long-term investor relationships grounded in transparency and trust, and on helping